Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast carcinoma

Cancer

Volumn 98, Issue 1, 2003, Pages 11-17

  Van der Sangen, Maurice J C ^a,b   Coebergh, Jan Willem W ^b,c   Roumen, Rudi M H ^b,d   Rutten, Harm J T ^a,b   Vreugdenhil, Gerard ^b,d   Voogd, Adri C ^b,e  

^a CATHARINA HOSPITAL   (Netherlands)

^b Eindhoven   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MÁXIMA MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Axillary dissection; Breast carcinoma; Diagnosis; Prognosis; Supraclavicular recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; INVASIVE CARCINOMA; NETHERLANDS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT INDICATION;

AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0038340841     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11469     Document Type: Article

References (18)

1. Debois JM. The significance of a supraclavicular node metastasis in patients with breast cancer. A literature review. Strahlenther Onkol. 1997;173:1-12.
2. Hietanen P, Miettinen M, Makinen J. Survival after first recurrence in breast cancer. Eur J Cancer Clin Oncol. 1986;22:913-919.
3. Hirn-Stadler B. The supraclavicular recurrence from breast cancer. Strahlenther Onkol. 1990;166:774-777.
4. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B. Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys. 1992;23:285-291.
5. Kiricuta IC, Willner J, Kölbl O, Bohndorf W. The prognostic significance of the supraclavicular lymph node metastases in breast cancer patients. Int J Radiat Oncol Biol Phys. 1993;28:387-393.
6. Voogd AC, van Beek MW, Crommelin MA, Kluck HM, Repelaer van Driel OJ, Coebergh JW. Management of early breast cancer in the Southeastern Netherlands since 1984: a population based study. Regional Breast Cancer Study Group. Acta Oncol. 1994;33:753-757.
7. Jackson SM, Carcinoma of the breast - the significance of supraclavicular lymph node metastases. Clin Radiol. 1966;17:107-114.
8. Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: the University of Texas M. D. Anderson Cancer Center Experience. J Clin Oncol. 2001;19:628-633.
9. Fentiman IS, Lavelle MA, Caplan D, Miller N, Millis RR, Hayward JL. The significance of supraclavicular fossa node recurrence after radical mastectomy. Cancer. 1986;57:908-1009.
10. Treurniet-Donker AD, Helle PA, van Putten WL. Adjuvant post-operative radiotherapy in operable node positive mammary cancer: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys. 1986;12:2067-2072.
11. De Boer R, Hillen HF, Roumen RM, Rutten HJ, van der Sangen MJ, Voogd AC. Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer. Br J Surg. 2001;88:118-122.
12. Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16:3375-3379.
13. Schirrmeister H, Guhlmann A, Kotzerke J, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol. 1999;17:2381-2389.
14. Abraham R, Nagy T, Goss PE, Crump M. High dose chemotherapy and autologous stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases. Cancer. 2000;88:790-795.
15. Pergolizzi S, Settineri N, Santacaterina A, et al. Ipsilateral supraclavicular lymph node metastases from breast cancer as only site of disseminated disease. Chemotherapy alone vs. induction chemotherapy to radical radiation therapy. Ann Oncol. 2001;12:1091-1095.
16. Borner M, Bacchi M, Goldhirsch A, et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a Phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol. 1994;12:1071-1077.
17. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours, 6th edition. New York: John Wiley & Sons, 2002:131-141.
18. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-3636.